Recombinant Hirudin Medicine Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Dosage Type ( 12000 ATU / mg, 16000 ATU / mg, Others ); Disease Indication ( Heparin-Induced Thrombocytopenia, Unstable Angina, Tumors, Others ) , and Geography (North America, Europe, Asia Pacific, and South and Central America)